Skip to main content
. Author manuscript; available in PMC: 2009 Aug 1.
Published in final edited form as: Metabolism. 2008 Aug;57(8):1148–1154. doi: 10.1016/j.metabol.2008.03.022

Table 1. Inhibition of insulin release from rat pancreatic islets by inhibitors of α-ketoglutarate hydroxylases.

Islets were incubated in the presence of the secretagogues for 1 h. Inhibitors were added 10 min before the secretagogues. The concentration of glucose was 16.7 mM and the concentrations of leucine and glutamine were 10 mM. Results are the mean ± SE (n = 6 to 12 replicate incubations for each condition)

Secretagogue Inhibitor Insulin Release(μU Insulin/5 islets/ 60 min.)
None None 20 ± 2
Glucose None 841 ± 63
Glucose 1 mM Ethyl-3,4-dihydroxybenzoate 48 ± 5a
Glucose 10 mM 2-Methyl-α-ketoglutarate 54 ± 7a
Glucose 5 mM 2-Methyl-α-ketoglutarate 291 ± 21a
Glucose 10 mM 3-Methyl-α-ketoglutarate 315 ± 29a
Leucine + glutamine None 1094 ± 105
Leucine + glutamine 1 mM Ethyl-3,4-dihydroxybenzoate 72 ± 24a
a

p < 0.001 vs same secretagogue condition without inhibitor